✦ LIBER ✦

Thymostimulin in advanced hepatocellular carcinoma: A phase II trial

✍ Scribed by Matthias M Dollinger; Christa M Behrens; Joachim Lesske; Susanne Behl; Curd Behrmann; Wolfgang E Fleig

Book ID: 115011490
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 304 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-72

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

Thymostimulin versus placebo for palliat

Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial

✍ Matthias M Dollinger; Christine Lautenschlaeger; Joachim Lesske; Andrea Tannapfe 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 748 KB

A Phase II trial of nolatrexed dihydroch

A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma

✍ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha

A phase II trial of tamoxifen in hepatoc

A phase II trial of tamoxifen in hepatocellular carcinoma

✍ Paul F. Engstrom; Bernard Levin; Charles G. Moertel; Allan Schutt 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

Phase II trial of sorafenib in combinati

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

✍ Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro